XOMA (US) LLC — TTAB Proceedings
XOMA (US) LLC is a party to 3 TTAB proceedings.
Proceedings
- Proceeding 86088564 — Extensions of Time to Oppose, Terminated (filed 2014-04-24) against Meda Pharmaceuticals Inc. as defendant
- Proceeding 91215704 — Oppositions, Terminated (filed 2014-04-02) against Merck Sharp & Dohme Corp. as defendant
- Proceeding 86056582 — Extensions of Time to Oppose, Terminated (filed 2014-02-25) against Merck Sharp & Dohme Corp. as defendant
Marks in These TTAB Matters
Recent Live Filings
- XOMA ROYALTY — Pending, filed 2024-03-28
- XOMA — Registered, filed 2018-07-30
- XOMA — Registered, filed 2018-07-30
- XOMA — Registered, filed 2018-01-22
- XOMA — Registered, filed 2018-01-22
Common TTAB Counterparties
- Merck Sharp & Dohme Corp. — 2 proceedings
- Meda Pharmaceuticals Inc. — 1 proceedings
Recent TTAB Timeline
- 2014-06-12: 91215704 — TERMINATED involving Merck Sharp & Dohme Corp.
- 2014-06-11: 91215704 — BD'S DECISION: DISMISSED W/O PREJUDICE involving Merck Sharp & Dohme Corp.
- 2014-06-05: 91215704 — WITHDRAWAL OF APPLICATION involving Merck Sharp & Dohme Corp.
- 2014-05-27: 86088564 — EXTENSION OF TIME GRANTED involving Meda Pharmaceuticals Inc.
- 2014-05-27: 86088564 — INCOMING - EXT TIME TO OPPOSE FILED involving Meda Pharmaceuticals Inc.
- 2014-05-09: 91215704 — EXTENSION OF TIME GRANTED involving Merck Sharp & Dohme Corp.
- 2014-05-09: 91215704 — STIPULATION FOR AN EXTENSION OF TIME involving Merck Sharp & Dohme Corp.
- 2014-04-24: 86088564 — EXTENSION OF TIME GRANTED involving Meda Pharmaceuticals Inc.
- 2014-04-24: 86088564 — INCOMING - EXT TIME TO OPPOSE FILED involving Meda Pharmaceuticals Inc.
- 2014-04-02: 91215704 — PENDING, INSTITUTED involving Merck Sharp & Dohme Corp.
- 2014-04-02: 91215704 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Merck Sharp & Dohme Corp.
- 2014-04-02: 91215704 — FILED AND FEE involving Merck Sharp & Dohme Corp.
- 2014-02-25: 86056582 — EXTENSION OF TIME GRANTED involving Merck Sharp & Dohme Corp.
- 2014-02-25: 86056582 — INCOMING - EXT TIME TO OPPOSE FILED involving Merck Sharp & Dohme Corp.